Pericyte loss in diabetic retinopathy: Mechanisms and consequences

Current Medicinal Chemistry

Volumn 20, Issue 26, 2013, Pages 3218-3225

  Beltramo, Elena ^a   Porta, Massimo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Apoptosis; Diabetic retinopathy; Endothelial cells; Extracellular matrix; Pericyte loss; Pericytes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; ENDOTHELIN 1; GLUCOSE; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN BAX; VASCULOTROPIN;

APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; BLOOD VESSEL TONE; CAPILLARY; CELL FUNCTION; CELL HYPOXIA; CELL INTERACTION; CELL PROLIFERATION; CELL STRUCTURE; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MESENCHYME CELL; MESODERM; METABOLITE; PATHOGENESIS; PERFUSION PRESSURE; PERICYTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE FIBER;

ANIMALS; APOPTOSIS; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; HUMANS; MICROVESSELS; PERICYTES;

EID: 84883229556     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113209990022     Document Type: Article

References (124)

1. Porta, M. Endothelium: the main actor in the remodelling of the retinal microvasculature in diabetes. Diabetologia, 1996; 39, 739-744.
2. Schalkwijk, C.G.; Stehouwer, C.D. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin. Sci. (Lond), 2005, 109(2), 143-159.
3. Cines, D.B.; Pollak, E.S.; Buck, C.A.; Loscalzo, J.; Zimmerman, G.A.; McEver, R.P.; Pober, J.S.; Wick, T.M.; Konkle, B.A.; Schwartz, B.S.; Barnathan, E.S.; McCrae, K.R.; Hug, B.A.; Schmidt, A.M.; Stern, D.M. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood, 1998, 91, 3527-3561.
4. Tsilibary, E.C. Microvascular basement membranes in diabetes mellitus. J. Pathol., 2003, 200, 537-546.
5. Armulik, A.; Abramsson, A; Betsholtz, C. Endothelial/pericyte interactions. Circ. Res., 2005, 97, 512-523.
6. Hammes, H.P. Pericytes and the pathogenesis of diabetic retinopathy. Horm. Metab. Res., 2005, 37 (Suppl. 1), 39-43.
7. Chakravarthy, U.; Gardiner, T.A. Endothelium-derived agents in pericyte function/dysfunction. Prog. Retin. Eye Res., 1999, 18, 511-527.
8. Etchevers, H.C.; Vincent, C.; Le Douarin, N.M.; Couly, G.F. The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development, 2001, 128, 1059-1068.
9. Hayden, M.R.; Yang, Y.; Habibi, J.; Bagree, S.V.; Sowers, J.R. Pericytopathy: oxidative stress and impaired cellular longevity in the pancreas and skeletal muscle in metabolic syndrome and type 2 diabetes. Oxid. Med. Cell. Longev., 2010, 3, 290-303.
10. Rouget, C. Mémoire sur les développement, la structure et les propriétés physiologiques des capillaires sanguins et lymphatiques. Arch. Physiol. Norm. Pathol., 1873, 5, 603-633.
11. Zimmerman, K.W. Der feinere Bau der Blut capillaren. Z. Anat. Entwicklungsgesch, 1923, 68, 3-109.
12. Kubawara, T.; Carroll, J.M.; Cogan, D.G. Retinal vascular patterns. III. Age, hypertension, absolute glaucoma, injury. Arch. Ophthalmol., 1961, 65, 708-716.
13. Cogan, D.; Toussaint, D.; Kubawara, T. Retinal vascular patterns. IV. Diabetic retinopathy. Arch. Ophthalmol., 1961, 66, 366-378.
14. Sims, D.E. Diversity within pericytes. Clin. Exp. Pharmacol. Physiol., 2000, 27: 842-846.
15. Pfister, F.; Lin, J.; Hammes, H.P. Pericyte Loss in the Diabetic Retina. In: Experimental Approaches to Diabetic Retinopathy; Hammes, H.P.; Porta, M. Eds.; Front Diabetes, Karger: Basel, 2010; Vol. 20, pp. 61-78.
16. Hughes, S.; Chan-Ling, T. Characterization of smooth muscle cell and pericyte differentiation in the rat retina in vivo. Invest. Ophthalmol. Vis. Sci., 2004, 45, 2795-2806.
17. DeRuiter, M.C.; Poelmann, R.E.; VanMunsteren, J.C.; Mironov, V.; Markwald, R.R.; Gittenberger-de-Groot, A.C. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ. Res., 1997, 80, 444-451.
18. Rajantie, I.; Ilmonen, M.; Alminaite, A.; Ozerdem, U.; Alitalo, K.; Salven, P. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood, 2004, 1, 104, 2084-2086.
19. Schwab, K.E.; Gargett, C.E. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum. Reprod., 2007, 22, 2903-2911.
20. Crisan, M.; Yap, S.; Casteilla, L.; Chen, C.W.; Corselli, M.; Park, T.S.; Andriolo, G.; Sun, B.; Zheng, B.; Zhang, L.; Norotte, C.; Teng, P.N.; Traas, J.; Schugar, R.; Deasy, B.M.; Badylak, S.; Buhring, H.J.; Giacobino, J.P.; Lazzari, L.; Huard, J.; Péault, B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell, 2008, 3, 301-313.
21. Corselli, M.; Chen, C.W.; Crisan, M.; Lazzari, L.; Péault, B. Perivascular ancestors of adult multipotent stem cells. Arterioscler. Thromb. Vasc. Biol., 2010, 30, 1104-1109.
22. Caplan, A.I. All MSCs are pericytes? Cell Stem Cell, 2008, 3, 229-230.
23. Bexell, D.; Gunnarsson, S.; Tormin, A.; Darabi, A.; Gisselsson, D.; Roybon, L.; Scheding, S.; Bengzon, J. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol. Ther., 2009, 17, 183-190.
24. Sims, D.E. Recent advances in pericyte biology. Implications for health and disease. Can. J. Cardiol., 1991, 7, 431-443.
25. Shepro, D.; Morel, N.M. Pericyte physiology. FASEB J., 1993, 7:1031-1038.
26. Sims, D.E. The pericyte: a review. Tissue Cell, 1986, 18:153-174.
27. Canfield, A.E.; Allen, T.D., Grant, M.E.; Schor, S.L.; Schor, A.M. Modulation of extracellular matrix biosynthesis by bovine retinal pericytes in vitro: effects of the substratum and cell density. J. Cell. Sci., 1990, 96 (Pt 1), 159-169.
28. Rucker, H.K.; Wynder, H.J.; Thomas, W.E. Cellular mechanisms of CNS pericytes. Brain Res. Bull., 2000, 51, 363-369.
29. Peppiatt, C.M.; Howarth, C.; Mobbs, P.; Attwell, D. Bidirectional control of CNS capillary diameter by pericytes. Nature, 2006, 443, 700-704.
30. Munaron, L.; Fiorio Pla A. Endothelial calcium machinery and angiogenesis: understanding physiology to interfere with pathology. Curr. Med. Chem., 2009, 16, 4691-4703.
31. Ueno, M. Molecular anatomy of the brain endothelial barrier: an overview of the distributional features. Curr. Med. Chem., 2007, 14, 1199-1206.
32. Ueno, M.; Nakagawa, T.; Wu, B.; Onodera, M.; Huang, C.L.; Kusaka, T.; Araki, N.; Sakamoto, H. Transporters in the brain endothelial barrier. Curr. Med. Chem., 2010, 17, 1125-1138.
33. Giebel, S.J.; Menicucci, G.; McGuire, P.G.; Das, A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab. Invest., 2005, 85, 597-607.
34. Fujimoto, K. Pericyte-endothelial gap junctions in developing rat cerebral capillaries: a fine structural study. Anat. Rec., 1995, 242, 562-565.
35. Hirschi, K.K.; D'Amore, P.A. Pericytes in the microvasculature. Cardiovasc. Res., 1996, 32, 687-698.
36. Gerhardt, H.; Betsholtz, C. Endothelial-pericyte interactions in angiogenesis. Cell. Tissue Res., 2003, 314, 15-23.
37. Hammes, H.P.; Lin, J.; Renner, O.; Shani, M.; Lundqvist, A.; Betsholtz, C.; Brownlee, M.; Deutsch, U. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes, 2002, 51, 3107-3112.
38. Lindahl, P.; Johansson, B.R.; Levéen, P.; Betsholtz, C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science, 1997, 277, 242-245.
39. Hellström, M.; Kalén, M.; Lindahl, P.; Abramsson, A.; Betsholtz, C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development, 1999, 126, 3047-3055.
40. Ramsauer, M.; D'Amore, P.A. Getting Tie(2)d up in angiogenesis. J. Clin. Invest., 2002, 110, 1615-1617.
41. Martin, A.R.; Bailie, J.R.; Robson, T.; McKeown, S.R.; Al-Assar, O.; McFarland, A.; Hirst, D.G. Retinal pericytes control expression of nitric oxide synthase and endothelin-1 in microvascular endothelial cells. Microvasc. Res., 2000, 59, 131-139.
42. Bringmann, A.; Pannicke, T.; Grosche, J.; Francke, M.; Wiedemann, P.; Skatchkov, S.N.; Osborne, N.N.; Reichenbach, A. Müller cells in the healthy and diseased retina. Prog. Retin. Eye Res., 2006, 25, 397-424.
43. Engerman, R.L. Pathogenesis of diabetic retinopathy. Diabetes, 1989, 38, 1203-1206.
44. Benjamin, L.E. Glucose, VEGF-A, and diabetic complications. Am. J. Pathol., 2001, 158, 1181-1184.
45. Frank, R.N. Diabetic retinopathy. N. Engl. J. Med., 2004, 350, 48-58.
46. Li, W.; Liu, X.; Yanoff, M.; Cohen, S.; Ye, X. Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells. Diabetologia, 1996, 39, 537-547.
47. Naruse, K.; Nakamura, J.; Hamada, Y.; Nakayama, M.; Chaya, S.; Komori, T.; Kato, K.; Kasuya, Y.; Miwa, K.; Hotta, N. Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes. Exp. Eye Res., 2000, 71, 309-315.
48. Romeo, G.; Liu, W.H.; Asnaghi, V.; Kern, T.S.; Lorenzi, M. Activation of nuclear factor-kappa B induced by diabetes and high glucose regulates a pro-apoptotic program in retinal pericytes. Diabetes, 2002, 51, 2604-2611.
49. Beltramo, E.; Berrone, E.; Buttiglieri, S.; Porta, M. Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose. Diabetes Metab. Res. Rev., 2004, 20, 330-336.
50. Amano, S.; Yamagishi, S.; Inagaki, Y.; Nakamura, K.; Takeuchi, M.; Inoue, H.; Imaizumi, T. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes. Microvasc. Res., 2005, 69, 45-55.
51. Beltramo, E.; Nizheradze, K.; Berrone, E.; Tarallo, S.; Porta, M. Thiamine and benfotiamine prevent apoptosis induced by high glucose-conditioned extracellular matrix in human retinal pericytes. Diabetes Metab. Res. Rev., 2009, 25, 647-656.
52. Beltramo, E.; Berrone, E.; Tarallo, S.; Porta, M. Different apoptotic responses of human and bovine pericytes to fluctuating glucose levels and protective role of thiamine. Diabetes Metab. Res. Rev., 2009, 25, 566-576.
53. Risso, A.; Mercuri, F.; Quagliaro, L.; Damante, G.; Ceriello; A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am. J. Physiol. Endocrinol. Metab., 2001, 281, E924-930.
54. Quagliaro, L.; Piconi, L.; Assaloni, R.; Martinelli, L.; Motz, E.; Ceriello, A. Intermittent high glucose enhances apoptosis relate to oxidative stress in human umbilical vein endothelial cells. Diabetes, 2003, 52, 2795-2804.
55. Piconi, L.; Quagliaro, L.; Assaloni, R.; Da Ros, R.; Maier, A.; Zuodar, G.; Ceriello, A. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diab. Met. Res. Rev., 2006, 22, 198-203.
56. Ihnat, M.A.; Thorpe, J.E.; Kamat, C.D.; Szabó, C.; Green, D.E.; Warnke, L.A.; Lacza, Z.; Cselenyák, A.; Ross, K.; Shakir, S.; Piconi, L.; Kaltreider, R.C.; Ceriello, A. Reactive oxygen species mediate a cellular "memory" of high glucose stress signalling. Diabetologia, 2007, 50, 1523-1531.
57. Bonora, E.; Muggeo, M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia, 2001, 44, 2107-2114.
58. Shichiri, M.; Kishikawa, H.; Ohkubo, Y.; Wake, N. Long-Term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care, 2000, 23 (suppl.2), B21-B29.
59. Rassam, S.M.; Patel, V.; Kohner, E.M. The effect of experimental hypertension on retinal vascular autoregulation in humans: a mechanism for the progression of diabetic retinopathy. Exp. Physiol., 1995, 80, 53-68.
60. Hughes, S.J.; Wall, N.; Scholfield, C.N.; McGeown, J.G.; Gardiner, T.A.; Stitt, A.W.; Curtis, T.M. Advanced glycation end product modified basement membrane attenuates endothelin-1 induced [Ca2+]i signalling and contraction in retinal microvascular pericytes. Mol. Vis., 2004, 10, 996-1004.
61. Beltramo, E.; Berrone, E.; Giunti, S.; Gruden, G.; Cavallo Perin, P.; Porta, M. Effects of mechanical stress and high glucose on pericyte proliferation, apoptosis and contractile phenotype. Exp. Eye Res., 2006, 83, 989-994.
62. Pugliese, G.; Tilton, R.G.; Speedy, A.; Santarelli, E.; Eades, D.M.; Province, M.A.; Kilo, C.; Sherman, W.R.; Williamson, J.R. Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol. Diabetes, 1990, 39, 312-22.
63. Bank, N.; Mower, P.; Aynedjian, H.S.; Wilkes, B.M.; Silverman, S. Sorbinil prevents glomerular hyperperfusion in diabetic rats. Am. J. Physiol., 1989, 256(6 Pt 2), F1000-1006.
64. De Vriese, A.S.; Verbeuren, T.J.; Van de Voorde, J.; Lameire, N.H. ; Vanhoutte, P.M. Endothelial dysfunction in diabetes. Br. J. Pharmacol., 2000, 130: 963-974.
65. Beltramo, E.; Pomero, F.; Allione, A.; D'Alù, F.; Ponte, E.; Porta, M. Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia, 2002, 45, 416-419
66. Beltramo, E.; Buttiglieri, S.; Pomero, F.; Allione, A.; D'Alù, F.; Ponte, E.; Porta, M. A study of capillary pericyte viability on extracellular matrix produced by endothelial cells in high glucose. Diabetologia, 2003, 46, 409-415
67. Hall, A.P. Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy. Toxicol. Pathol., 2006, 34, 763-775.
68. Cagliero, E.; Maiello, M.; Boeri, D.; Roy, S.; Lorenzi, M. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J. Clin. Invest., 1988, 82, 735-738.
69. Cagliero, E.; Roth, T.; Roy, S.; Lorenzi, M. Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes, 1991, 40, 102-110.
70. Roth, T.; Podestá, F.; Stepp, M.A.; Boeri, D.; Lorenzi, M. Integrin overexpression induced by high glucose and by human diabetes: potential pathway to cell dysfunction in diabetic microangiopathy. Proc. Natl. Acad. Sci. U.S.A., 1993, 90, 9640-9644.
71. Casaroli Marano, R.P.; Preissner, K.T.; Vilaró, S. Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. Exp. Eye Res., 1995, 60, 5-17.
72. Preissner, K.T., Kanse, S.M., Hammes, H.P. Integrin chatter and vascular function in diabetic retinopathy. Horm. Metab. Res., 1997, 29, 643-645.
73. Podestà, F.; Roth, T.; Ferrara, F.; Cagliero, E.; Lorenzi, M. Cytoskeletal changes induced by excess extracellular matrix impair endothelial cell replication. Diabetologia, 1997, 40, 879-886.
74. Roy, S.; Nasser, S.; Yee, M.; Graves, D.T.; Roy, S. A long-Term siRNA strategy regulates fibronectin overexpression and improves vascular lesions in retinas of diabetic rats. Mol. Vis., 2011, 17, 3166-3174.
75. Di Mario, U.; Pugliese, G. 15th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes. Diabetologia, 2001, 44, 674-692.
76. DCCT: The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-Term complications in insulindependent diabetes mellitus. N. Engl. J. Med., 1993, 329, 977-986.
77. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352, 837-853.
78. Ströder, K.; Unger, T.; Steckelings, U.M. The Renin-Angiotensin System in the Eye. In: Experimental Approaches to Diabetic Retinopathy; Hammes, H.P.; Porta, M. Eds.; Front Diabetes, Karger: Basel, 2010; Vol. 20, pp. 142-157.
79. Paul, M.; Poyan Mehr, A.; Kreutz, R. Physiology of local reninangiotensin systems. Physiol. Rev., 2006, 86, 747-803.
80. Wagner, J.; Jan Danser, A.H.; Derkx, F.H.; de Jong, T.V.; Paul, M.; Mullins, J.J.; Schalekamp, M.A.; Ganten, D. Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br. J. Ophthalmol., 1996, 80, 159-63.
81. Carey, R.M.; Siragy, H.M. The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol. Metab., 2003, 14, 274-281.
82. Yamagishi, S.; Amano, S.; Inagaki, Y.; Okamoto, T.; Inoue, H.; Takeuchi, M.; Choei, H.; Sasaki, N.; Kikuchi, S. Angiotensin IItype 1 receptor interaction upregulates vascular endothelial growth factor messenger RNA levels in retinal pericytes through intracellular reactive oxygen species generation. Drugs Exp. Clin. Res., 2003, 29, 75-80.
83. Kawamura, H.; Kobayashi, M.; Li, Q.; Yamanishi, S.; Katsumura, K.; Minami, M.; Wu, D.M.; Puro, D.G. Effects of angiotensin II on the pericyte-containing microvasculature of the rat retina. J. Physiol., 2004, 561, 671-683.
84. Seshiah, P.N.; Weber, D.S.; Rocic, P.; Valppu, L.; Taniyama, Y.; Griendling, K.K. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ. Res., 2002, 91, 406-413.
85. Kato, H.; Suzuki, H.; Tajima, S.; Ogata, Y.; Tominaga, T.; Sato, A.; Saruta, T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J. Hypertens., 1991, 9, 17-22.
86. Ruiz-Ortega, M.; Lorenzo, O.; Rupérez, M.; König, S.; Wittig, B.; Egido, J. Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ. Res., 2000, 86, 1266-1272.
87. Thomas, M.C.; Tikellis, C.; Burns, W.M.; Bialkowski, K.; Cao, Z.; Coughlan, M.T.; Jandeleit-Dahm, K.; Cooper, M.E.; Forbes, J.M. Interactions between renin angiotensin system and advanced glycation in the kidney. J. Am. Soc. Nephrol., 2005, 16, 2976-2984.
88. Policha, A.; Daneshtalab, N.; Chen, L.; Dale, L.B.; Altier, C.; Khosravani, H.; Thomas, W.G.; Zamponi, G.W.; Ferguson, S.S. Role of angiotensin II type 1A receptor phosphorylation, phospholipase D, and extracellular calcium in isoform-specific protein kinase C membrane translocation responses. J. Biol. Chem., 2006, 281, 26340-26349.
89. Clements, R.S. Jr.; Morrison, A.D.; Winegrad, A.I. Polyol pathway in aorta: regulation by hormones. Science, 1969, 166, 1007-1008.
90. Hsieh, T.J.; Fustier, P.; Zhang, S.L.; Filep, J.G.; Tang, S.S.; Ingelfinger, J.R.; Fantus, I.G.; Hamet, P.; Chan, J.S. High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. Endocrinology, 2003, 144, 4338-4349.
91. Cao, Z.; Cooper, M.E.; Wu, L.L.; Cox, A.J.; Jandeleit-Dahm, K.; Kelly, D.J.; Gilbert, R.E. Blockade of the renin-angiotensin and endothelin systems on progressive renal injury. Hypertension, 2000, 36, 561-568.
92. Horio, N.; Horiguchi, M. Retinal blood flow and macular edema after radial optic neurotomy for central retinal vein occlusion. Am. J. Ophthalmol., 2006, 141, 31-34.
93. Zhang, J.Z.; Xi, X.; Gao, L.; Kern, T.S. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy. Curr. Eye Res., 2007, 32, 883-888
94. Chaturvedi, N.; Sjølie, A.K.; Stephenson, J.M.; Abrahamian, H.; Keipes, M.; Castellarin, A.; Rogulja-Pepeonik, Z.; Fuller, J.H. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet, 1998, 351, 28-31.
95. Chaturvedi, N.; Porta, M.; Klein, R.; Orchard, T.; Fuller, J.; Parving, H.H.; Bilous, R.; Sjølie, A.K., for the DIRECT Programme Study Group. Effect of candesartan on prevention (DIRECTPrevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet, 2008, 372, 1394-1402.
96. Sjølie, A.K.; Klein, R.; Porta, M.; Orchard, T.; Fuller, J.; Parving, H.H.; Bilous, R.; Chaturvedi, N., for the DIRECT Programme Study Group. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet, 2008, 372, 1385-1393.
97. Nishikawa, T.; Edelstein, D.; Brownlee, M. The missing link: A single unifying mechanism for diabetic complications. Kidney Int., 2000, 58, S26-S30.
98. Brignardello, E.; Beltramo, E.; Molinatti, P.A.; Aragno, M.; Gatto, V.; Tamagno, E.; Danni, O.; Porta, M.; Boccuzzi, G. Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. J. Endocrinol., 1998, 158, 21-26.
99. Podestà, F.; Romeo, G.; Liu, W.H.; Krajewski, S.; Reed, J.C.; Gerhardinger, C.; Lorenzi, M. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am. J. Pathol., 2000, 156, 1025-1032.
100. Van Ballegooie, E.; Hooymans, J.M.; Timmerman, Z.; Reitsma, W.D.; Sluiter, W.J.; Schweitzer, N.M.; Doorenbos, H. Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care, 1984, 7, 236-242.
101. Dandona, P.; Bolger, J.P.; Boag, F.; Fonesca, V.; Abrams, J.D. Rapid development and progression of proliferative retinopathy after strict diabetic control. Br. Med. J., 1985, 290, 885-896.
102. Dahl-Jorgensen, K.; Brinchmann-Hansen, O.; Hanssen, K.F.; Sandvik, L.; Aagenages, O. Rapid tightening of blood glucose levels leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus. Br. Med. J., 1985, 290, 811-815.
103. Engerman, R.L.; Kern, T.S. Progression of incipient diabetic retinopathy during good glycaemic control. Diabetes, 1987, 36, 808-812.
104. Beltramo, E.; Berrone, E.; Tarallo, S.; Porta, M. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta Diabetol., 2008, 45, 131-141.
105. Williamson, J.R.; Chang, K.; Frangos, M.; Hasan, K.S.; Ido, Y.; Kawamura, T.; Nyengaard, J.R.; Van Den Enden, M.; Kilo, C.; Tilton, R.G. Hyperglycemic pseudoypoxia and diabetic complications. Diabetes, 1993, 42, 801-813.
106. Lee, A.Y.; Chung, S.S. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J., 1999, 13, 23-30.
107. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001, 414, 813-820.
108. Baynes, J.W. Role of oxidative stress in development of complications in diabetes. Diabetes, 1991, 40, 405-412.
109. Giardino, I.; Edelstein, D.; Brownlee, M. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J. Clin. Invest. 1994, 94, 110-117.
110. Charonis, A.S.; Reger, L.A.; Dege, J.E.; Kouzi-Koliakos, K.; Furcht, L.T.; Wohlhueter, R.M.; Tsilibary, E.C. Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes, 1990, 39, 807-814.
111. Doi, T.; Vlassara, H.; Kirstein, M.; Yamada, Y.; Striker, G.E.; Striker, L.J. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci U.S.A., 1992, 89, 2873-2877.
112. Schmidt, A.M.; Hori, O.; Chen, J.X.; Li, J.F.; Crandall, J.; Zhang, J.; Cao, R.; Yan, S.D.; Brett, J.; Stern, D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest., 1995, 96, 1395-1403.
113. Koya, D.; King, G.L. Protein kinase C activation and the development of diabetic complications. Diabetes, 1998, 47, 859-866.
114. Koya, D.; Jirousek, M.R.; Lin, Y.W.; Ishii, H.; Kuboki, K.; King, G.L. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J. Clin. Invest., 1997, 100, 115-126.
115. Nishikawa, T.; Edelstein, D.; Du, X.L.; Yamagishi, S.; Matsumura, T.; Kaneda, Y.; Yorek, M.A.; Beebe, D.; Oates, P.J.; Hammes, H.P.; Giardino, I.; Brownlee, M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 2000, 404,787-790.
116. Schleicher, E.D.; Weigert, C. Role of the hexosamine biosyntetic pathway in diabetic nephropathy. Kidney Int., 2000, 77, S13-18.
117. Du, X.L.; Edelstein, D.; Rossetti, L.; Fantus, I.G.; Goldberg, H.; Ziyadeh, F.; Wu, J.; Brownlee, M. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. U.S.A., 2000, 97, 12222-12226.
118. Du, X.L.; Matsumura, T.; Edelstein, D.; Rossetti, L.; Zsengellér, Z.; Szabó, C.; Brownlee, M. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J. Clin. Invest., 2003, 112, 1049-1057.
119. Wu, M.; Chen, Y.; Wilson, K.; Chirindel, A.; Ihnat, M.A.; Yu, Y.; Boulton, M.E.; Szweda, L.I.; Ma, J.X.; Lyons T.J. Intraretinal leakage and oxidation of LDL in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci., 2008, 49, 2679-2685.
120. Fu, D.; Wu, M.; Zhang, J.; Du, M.; Yang, S.; Hammad, S.M.; Wilson, K.; Chen, J.; Lyons, T.J. Mechanisms of modified LDLinduced pericyte loss and retinal injury in diabetic retinopathy. Diabetologia, 2012, 55, 3128-3140.
121. Pfister, F.; Feng, Y.; vom Hagen, F.; Hoffmann, S.; Molema, G.; Hillebrands, J.L.; Shani, M.; Deutsch, U.; Hammes, H.P. Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes, 2008, 57, 2495-2502.
122. Trudeau, K.; Molina, A.J.; Roy, S. High glucose induces mitochondrial morphology and metabolic changes in retinal pericytes. Invest. Ophthalmol. Vis. Sci., 2011, 52, 8657-8664.
123. Tu, Z.; Li, Y.; Smith, D.S.; Sheibani, N.; Huang, S.; Kern, T.; Lin, F. Retinal pericytes inhibit activated T cell proliferation. Invest. Ophthalmol. Vis. Sci., 2011, 52, 9005-9010.
124. Li, Y.; Smith, D.; Li, Q.; Sheibani, N.; Huang, S.; Kern, T.; Nagaraj, R.H.; Lin, F. Antibody-mediated retinal pericyte injury: implications for diabetic retinopathy. Invest. Ophthalmol. Vis. Sci., 2012, 53, 5520-5526.